TrialJournal of endocrinological investigation

Improved post-prandial ghrelin response by nateglinide or acarbose therapy contributes to glucose stability in Type 2 diabetic patients.

F Zheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.